U.S. seeks DaVita’s records on drug claims
- Share via
From Bloomberg News
DaVita Inc., a provider of dialysis services, said U.S. investigators had asked for records of drug claims made to Medicare, the government health program for the elderly and disabled.
The request, from the inspector general of the Health and Human Services Department, concerns claims related to the drug Epogen, the El Segundo-based company said. The medicine is made by Amgen Inc. and given to treat anemia in dialysis patients whose kidneys have failed.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.